Articles Tagged With:
-
Vomiting and Diarrhea in Immunocompromised Patients
Patients who are immunosuppressed may exhibit subtle or atypical presentations of gastrointestinal infection, as well as complications of their underlying disease processes or treatments. Emergency physicians should maintain a high level of suspicion for life-threatening pathology and evaluate these patients using broad differentials.
-
High Blood Pressure Control, Awareness on the Decline Among U.S. Adults
Health groups lament a trend that could undo years of work.
-
Infectious Disease Alert Updates
IL-6 Inhibition and Liver Failure; Can Chopsticks Make You Sick?
-
Vitamin C, Thiamine, and Steroids for Septic Shock — Still Unproven
Combination treatment with ascorbic acid (vitamin C), thiamine (vitamin B1), and corticosteroids does not improve clinical outcomes in adults with septic shock.
-
Biofilm, Tap Water, and a Nosocomial Mycobacterium abscessus Outbreak — Bring on the Sterile Water
Stopping a nosocomial Mycobacterium abscessus outbreak by eschewing tap water.
-
Possible Aerosol Spread of SARS-CoV-2 in an Apartment Building
Although not definitive, evidence is consistent with aerosol spread of SARS-CoV-2 in an apartment building as a result of transport through the drainage system to apartments directly above.
-
Four Months of Rifampin Is Just as Effective, Safer, and Less Expensive than Nine Months of Isoniazid for Latent Tuberculosis
A health system cost comparison found that four months of rifampin was safer and less expensive than nine months of isoniazid in high-income countries, medium-income countries, and African countries.
-
Antibiotic Use in COVID-19 Patients
Fifty-seven percent of patients with COVID-19 infection treated at 38 hospitals in Michigan received early empiric antibiotics, although only 3.5% of patients had documented community-onset bacterial co-infection.
-
Seasonal Coronavirus: A “Common Cold Virus” that May Be Lethal in Severely Immunocompromised Patients
Seasonal coronaviruses, which are a frequent cause of benign upper respiratory tract infections, may be fatal in severely immunocompromised patients.
-
Repeat SARS-CoV-2 Infection
Whole genome sequencing confirmed that repeat infection with SARS-CoV-2 is possible, something that has consequences for vaccine use and for public health.